Major asset management firms, including
Shell Asset Management and
Canada Pension Plan Investment Board, have been reducing their holdings in
Zimmer Biomet Holdings, Inc. (ZBH), while others like
EP Wealth Advisors and
Bessemer Group Inc. are buying in. Some reports emphasize that the stock may be
undervalued by up to 45%.
ZBH reported strong growth in
Q4 and full-year 2023 financial results, boosting its momentum despite underperforming compared to competitors on some days.
ZBH also outlined its
growth plan for future success, showing promising return trends. The company has announced several Q1 and Q4 2023 earnings, yet its shares haven't performed consistently. Notably,
ZBH expanded its product line by entering a distribution agreement with
THINK Surgical to offer a robotic system for knee replacement surgery and received
FDA clearance for its
ROSA® Shoulder System, the world's first robotic assistant for shoulder replacement surgery.
Zimmer Biomet Holdings ZBH News Analytics from Tue, 26 Sep 2023 07:00:00 GMT to Sun, 28 Jul 2024 16:42:01 GMT -
Rating 4
- Innovation 7
- Information 8
- Rumor 3
